Tower Research Capital (TRC)’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $43.4K | Buy |
18,021
+9,870
| +121% | +$23.8K | ﹤0.01% | 3092 |
|
|
2025
Q1 | $18K | Buy |
8,151
+4,177
| +105% | +$9.23K | ﹤0.01% | 3070 |
|
|
2024
Q4 | $21.7K | Sell |
3,974
-11,324
| -74% | -$61.7K | ﹤0.01% | 3126 |
|
|
2024
Q3 | $127K | Buy |
15,298
+9,955
| +186% | +$82.7K | ﹤0.01% | 2042 |
|
|
2024
Q2 | $38.3K | Sell |
5,343
-19,318
| -78% | -$138K | ﹤0.01% | 3299 |
|
|
2024
Q1 | $214K | Buy |
24,661
+18,563
| +304% | +$161K | 0.01% | 1366 |
|
|
2023
Q4 | $39.9K | Sell |
6,098
-8,936
| -59% | -$58.5K | ﹤0.01% | 3278 |
|
|
2023
Q3 | $150K | Buy |
15,034
+12,049
| +404% | +$120K | ﹤0.01% | 1653 |
|
|
2023
Q2 | $37.1K | Sell |
2,985
-2,014
| -40% | -$25K | ﹤0.01% | 2812 |
|
|
2023
Q1 | $70K | Buy |
4,999
+2,863
| +134% | +$40.1K | ﹤0.01% | 2202 |
|
|
2022
Q4 | $30K | Buy |
2,136
+1,270
| +147% | +$17.8K | ﹤0.01% | 2746 |
|
|
2022
Q3 | $22K | Sell |
866
-14,487
| -94% | -$368K | ﹤0.01% | 3865 |
|
|
2022
Q2 | $436K | Buy |
15,353
+7,170
| +88% | +$204K | 0.01% | 1226 |
|
|
2022
Q1 | $289K | Buy |
8,183
+7,037
| +614% | +$249K | ﹤0.01% | 1489 |
|
|
2021
Q4 | $48K | Sell |
1,146
-379
| -25% | -$15.9K | ﹤0.01% | 2788 |
|
|
2021
Q3 | $75K | Sell |
1,525
-2,020
| -57% | -$99.3K | ﹤0.01% | 2636 |
|
|
2021
Q2 | $148K | Buy |
3,545
+2,637
| +290% | +$110K | ﹤0.01% | 2136 |
|
|
2021
Q1 | $32K | Buy |
+908
| New | +$32K | ﹤0.01% | 3523 |
|